TRPC1 and breast cancer: Overexpression of EPDR1 inhibited PI3K/AKT signaling pathway activation in Epirubicin-resistant BC cells, and silencing TRPC1 reversed the inhibitory effect of EPDR1 overexpression on PI3K/AKT signaling pathway in epirubicin-resistant BC cells.